Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-29 @ 12:13 AM
Study NCT ID:
NCT00038259
Status:
COMPLETED
Last Update Posted:
2021-11-01
First Post:
2002-05-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-05
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-29
First Submit QC Date:
None
Study First Post Date:
2002-05-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-28
Last Update Post Date:
2021-11-01
Last Update Post Date Type:
ACTUAL